MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    PDQ-39 predicts quality of life improvement following neurostimulation for Parkinson’s disease: Prospective observational study

    L. Torrão, M. Rosas, J. Massano, A. Oliveira, C. Chamadoira, M. Rito, J. Guimarães, C. Soares (Póvoa de Varzim, Portugal)

    Objective: The primary outcome was assessing QoL of a cohort of patients with PD before and after undergoing DBS surgery, measured using PDQ-39 questionary. Secondary…
  • 2023 International Congress

    Observations on 5 Parkinson’s patients taking Mucuna pruriens as natural source of levodopa

    S. Elsas (Arlesheim, Switzerland)

    Objective: To explore potential benefits and tolerability of extracts from Mucuna pruriens for dopaminergic treatment of Parkinson’s patients. Background: Capsules containing freeze-dried, aqueous extract from…
  • 2023 International Congress

    Pronounced Cervical Dystonia in Ataxia with Vitamin E Deficiency

    M. Soares, T. Guimarães, J. Parmera, M. Oliveira, R. Barbosa, F. Kok, E. Barbosa, R. Cury (São Paulo, Brazil)

    Objective: Objective: To describe a case report of an atypical phenotype of ataxia with vitamin E deficiency (AVED) and marked cervical dystonia. Background: Background: AVED…
  • 2023 International Congress

    The incidence of Parkinson’s disease in Nigeria: a systematic review and meta-analysis

    A. Memudu, E. Ekhoye (Iyamho, Nigeria)

    Objective: The study aim to integrate various investigations pertaining to the incidence of Parkinson's disease (PD) in Nigeria, with the objective of comprehensively characterizing the…
  • 2023 International Congress

    Atypical parkinsonism syndromes: clinical presentations

    A. Gunduz, S. Akkus, FZ. Calikusu, E. Koçhan Kızılkılıç, B. Poyraz, A. Altunç, G. Kızıltan (Istanbul, Turkey)

    Objective: Here, our aim was to identify the characteristics of atypical clinical presentations of atypical parkinsonism syndromes in our cohort and our secondary aim was…
  • 2023 International Congress

    Deep brain stimulation modulates subthalamic beta bursts related to movement velocity adjustments in Parkinson’s disease

    M. Bange, G. Gonzalez-Escamilla, DM. Herz, G. Tinkhauser, M. Glaser, D. Ciolac, H. Tan, P. Brown, S. Groppa (Mainz, Germany)

    Objective: The aim of this study was to investigate the role of subthalamic beta bursts for dynamic control of precise drawing movements. Background: The performance…
  • 2023 International Congress

    Association Between Antiepileptic Drugs and Subsequent Parkinson’s Disease in East London

    Q. Zhang, J. Bestwick, R. Dobson, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To investigate the association between antiepileptic drugs (AEDs) prescription and subsequent Parkinson’s disease (PD). Background: Recent observational studies have highlighted an association between epilepsy…
  • 2023 International Congress

    The impact of biographic factors and lifestyle on the symptoms of Parkinson’s Disease – a five year follow-up

    J. Stögbauer, A. Bär, L. Schappe, U. Hillmann, K. Fassbender, C. Dupeyrat, D. Martens, J. Spiegel (Homburg, Germany)

    Objective: To identify biographic parameters that may have an impact on the different symptoms of parkinson’s disease. Background: Parkinson’s disease (PD) is a neurodegenerative movement…
  • 2023 International Congress

    Identification of a Metabolic Brain Pattern Specific to Corticobasal Degeneration and Its Utility in Differential Diagnosis

    T. Rus, J. Jamšek, M. Perovnik, M. Trošt (Ljubljana, Slovenia)

    Objective: To identify a metabolic brain pattern specific to corticobasal degeneration (CBD) and to develop a machine learning algorithm that can differentiate CBD from other…
  • 2023 International Congress

    White matter integrity in patients with PSP-RS and VaP: A TBSS Study

    K. Chatterjee, M. Tiwari, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: The purpose of the present study was to compare alterations of brain white-matter microstructure and tissue integrity in PSP-RS and VaP patients using Diffusion…
  • « Previous Page
  • 1
  • …
  • 417
  • 418
  • 419
  • 420
  • 421
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley